— Know what they know.
Not Investment Advice

ICVX NASDAQ

Icosavax, Inc.
1W: +0.0% 1M: +0.1% 3M: +47.5% 1Y: +87.2%
$15.31
Last traded 2024-02-29 — delisted
NASDAQ · Healthcare · Biotechnology · $769.0M mcap · 29M float · 4.23% daily turnover

Balance Sheet Trends

Total Assets
$239M -17.0% ▼
3Y CAGR: +117.2%
Total Liabilities
$21M +118.0% ▲
3Y CAGR: -13.3%
Shareholders Equity
$218M -21.6% ▼
Cash & Investments
$218M -21.8% ▼
3Y CAGR: +111.5%
Total Debt
$9M +0.0% ▲
Net Debt
-$50M +82.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022
— Assets —
Cash$23M$13M$279M$59M
Short-Term Investments$0$0$0$159M
Cash & ST Investments$23M$13M$279M$218M
Net Receivables$0$0$0$0
Inventory$0$0$0$0
Other Current Assets$209K$662K$6M$5M
Total Current Assets$23M$16M$287M$224M
Property, Plant & Equip.$0$10K$1M$15M
Goodwill & Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Other Non-Current Assets$0-$10K-$1M-$15M
Total Non-Current Assets$0$10K$1M$15M
Total Assets$23M$16M$288M$239M
— Liabilities —
Accounts Payable$799K$2M$4M$3M
Short-Term Debt$0$0$0$2M
Deferred Revenue$0$2M$582K$0
Other Current Liabilities$424K$2M$5M$9M
Total Current Liabilities$1M$6M$9M$14M
Long-Term Debt$0$5M$0$7M
Other Non-Current Liab.$30M$32M$171K$69K
Total Non-Current Liabilities$30M$37M$171K$7M
Total Liabilities$32M$43M$9M$21M
— Equity —
Common Stock$1K$2K$5K$6K
Retained Earnings-$8M-$27M-$94M-$186M
Accumulated OCI$0$0-$288M-$403K
Total Stockholders Equity-$8M-$27M$278M$218M
Total Liabilities & Equity$23M$16M$288M$239M
— Key Metrics —
Total Debt$0$5M$0$9M
Net Debt-$23M-$8M-$279M-$50M
Total Investments$0$0$0$159M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms